Neurawear develops a wearable Brain-Computer Interface (BCI) combined with Functional Electrical Stimulation (FES) to provide continuous stroke rehabilitation at home, utilizing patented hydrogel electrode technology. This device addresses the lack of accessible and affordable rehabilitation options for over 80% of stroke patients who struggle to receive necessary motor recovery support.
Funding
Funding not disclosed
Founders
Product
Problem
Over 80% of stroke patients lack access to affordable and continuous motor rehabilitation, leading to limited recovery and persistent physical challenges. Current rehabilitation options are often confined to clinical settings, proving costly and inaccessible for many.
Solution
Neurawear is developing a wearable Brain-Computer Interface (BCI) device combined with Functional Electrical Stimulation (FES) to enable continuous stroke rehabilitation at home. Utilizing patented hydrogel electrode technology, the device seamlessly integrates into daily activities, providing convenient and effective motor rehabilitation. This on-the-go rehabilitation solution aims to improve patient outcomes by making BCI-FES technology accessible outside of clinical environments.
Target Audience
The primary target audience includes stroke patients seeking accessible and affordable at-home rehabilitation solutions, as well as clinicians and therapists looking to extend rehabilitation beyond the clinic.
Features
- Wearable BCI-FES device for continuous stroke rehabilitation integrated into daily activities
- Patented hydrogel electrode technology for enhanced signal acquisition and comfort
- Non-invasive brain-computer interface to detect and interpret motor intent
- Functional Electrical Stimulation (FES) to activate targeted muscles
- Personalized rehabilitation programs tailored to individual patient needs
- Real-time feedback and progress tracking to optimize therapy
- Wireless connectivity for data logging and remote monitoring